SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-18-058414
Filing Date
2018-11-08
Accepted
2018-11-08 17:02:16
Documents
54
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv505582_10q.htm 10-Q 443449
2 EXHIBIT 31.1 tv505582_ex31-1.htm EX-31.1 11273
3 EXHIBIT 32.1 tv505582_ex32-1.htm EX-32.1 4616
4 GRAPHIC tv505582_img1.jpg GRAPHIC 104385
  Complete submission text file 0001144204-18-058414.txt   5053275

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT syn-20180930.xml EX-101.INS 1472853
6 XBRL TAXONOMY EXTENSION SCHEMA syn-20180930.xsd EX-101.SCH 37329
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE syn-20180930_cal.xml EX-101.CAL 32582
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE syn-20180930_def.xml EX-101.DEF 232516
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE syn-20180930_lab.xml EX-101.LAB 270421
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE syn-20180930_pre.xml EX-101.PRE 263903
Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850 (734) 332-7800
Synthetic Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

IRS No.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12584 | Film No.: 181170468
SIC: 2834 Pharmaceutical Preparations